| INTRODUCTION
In-transit (IT) disease is a form of locoregional spread thought to represent the tumor dissemination within the dermal and subdermal lymphatics, and appears as the initial site of recurrence in approximately 2% to 10% of the patients with cutaneous melanoma. [1] [2] [3] [4] Clinically, IT lesions manifest as cutaneous or subcutaneous tumor nodules located between the primary melanoma and the regional draining lymph node basin(s). Different nomenclature has been used to describe this disease, using distance from the primary scar to classify the disease as local recurrence, satellites, or IT events.
With the exception of true local recurrences secondary to residual disease after inadequate resection, these terms are arbitrary and are all considered as the result of intralymphatic contamination and thus have poor prognosis. 5 IT disease often precedes the onset of systemic disease, with subsequent probability of survival ranging from 35% to 60% of 5 years. 6 In the absence of metastatic disease, resection of IT metastases is the treatment favored when technically feasible and if the associated morbidity is acceptable. The surgical principles for treating IT lesions differ from those of a primary melanoma. The main rationale for more conservative excision of IT lesions is the concern that most patients have microscopic contamination of the draining lymphatic network, and a high likelihood of occult distant disease, recurrence, and death. This is consistent with the American Joint Committee on Cancer staging system, which classifies these patients as stage III. 7 Radical surgery, to achieve wide margins in this situation, is considered to be unjustified as this can be disfiguring and is not felt to dramatically alter the natural history of the disease, as local failure at the site of the IT lesion is not the primary concern.
However, the incidence rates for subsequent local disease have been reported to be as high as 45%, suggesting that local control can be an issue for some patients. In addition, previous studies have shown that a subset of IT patients, without distant metastases, enjoy long-term relapse-free survival following surgical resection alone with curative intent. [8] [9] [10] Although there are no data that definitively address the gross or microscopic margin of resection in this population, the National Comprehensive Cancer Network (NCCN) recommends a complete surgical excision to clear margins in the absence of extensive metastatic disease.
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The objective of our retrospective study was to assess the patterns of failure and describe the natural history of melanoma in patients with their first IT event undergoing surgical resection at our institution, and to determine if surgical excision margins influence the risk of further local disease. This information is intended to better define how to manage patients with IT disease. By defining the patterns of failure, we intend to help address the issue if a systemic approach should be utilized at the time of a first IT event secondary to the risk of distant failure or should a more aggressive locoregional approach be undertaken? This is especially relevant in an era with increasingly effective systemic therapies. presented with clinical evidence of synchronous regional nodal disease at the time of IT recurrence are at a higher risk of distant metastasis based on the previous published data from our institution and were therefore excluded (n = 20). 12 All clinically node-negative patients were included, regardless of, if they did or did not undergo a sentinel lymph node biopsy at the time of their IT resection and regardless of the sentinel lymph node status, if performed. Our experience with regional lymph node staging in this population had previously been described. Gross clinical margins around the IT lesion at the time of excision were extracted from the operative note. When more than one IT lesion was present, the margin width of the lesion with the closest clinical margin was recorded. Histopathologic margins were assessed using an ocular micrometer, and extracted from the pathology report when available. For specimens that contained no residual tumor, the gross margin was defined as the closest peripheral margin reported, using half the size of the shortest dimension of the gross specimen plus 20%. Twenty percent gross specimen shrinkage was chosen, based on the data from previous studies, to translate in vitro (pathologic) to in vivo excision margin. 13 Local failure was defined as a biopsy confirmed melanoma lesion within 2 cm of the surgical scar following excision of the IT disease.
| MATERIALS AND METHODS
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Thus, lesions historically referred to as satellite nodules were included in our definition of local disease failure. This definition was chosen given the failure within 2 cm was the widest margin and, we felt, could be influenced by a more aggressive IT resection.
Disease more than 2 cm from the IT lesion, but not beyond the regional nodal basin, was defined as an IT event.
| Statistical analysis
Descriptive statistics were reported as numbers (percent) Multivariate analysis was performed using competing risk analysis techniques. Model building incorporated the SCORE selection approach. A two-sided P value less than 0.05 was considered significant. All analyses were done using SAS 9.4 computer software.
3 | RESULTS
| Patient characteristics
A total of 250 patients presented to our institution with IT disease over the study period. Patients were excluded due to nonsurgical treatment of their first IT event (n = 78), surgery performed at another institution (n = 15), evidence of clinical regional nodal disease at IT presentation (n = 20), or positive surgical margins (n = 7). The study cohort consists of 130 patients (53% male), where 12 patients (9%) presented with synchronous IT metastatic disease and an intact primary melanoma.
Fifty-three patients (41%) presented with a first IT event within a year of their primary diagnosis, and 65 patients (50%) presented with their first IT event in a year or more after their primary diagnosis. The median age at IT presentation was 62.8 years (IQR, 53.8 to 74.2) ( Table 1) .
Thirty patients had dermal lesions, 87 patients had subcutaneous lesions, and 13 patients had a combination of both. 
| Patterns of failure
When the data was locked, the 44 patients who were alive without the disease recurrence had followed a median of 2. first IT event. Among the 81 recurrences observed, there were few instances where the site(s) of failure after the first IT event was an isolated local failure (8 patients, 6%). A local failure was found more often in combination with another failure site (15 patients, 11.5%).
However, more than half of the failures observed were recurrences without the local failures (58 patients, 44.6%) ( Table 2 ).
| Local failure
The overall cumulative local failure was 19.5% (95% confidence head and neck vs trunk: P = 0.13), or diameter of the largest IT lesion greater than or equal to 10 mm (P = 0.35) ( Table 3 ).
Multivariate analysis found higher local failure rates in patients with a DFI of less than a year (hazard ratio [HR], 2.66; 95% CI, 1.10 to 6.40; P = 0.03) and more than a single IT lesion at presentation (HR, 4.48; 95% CI, 1.94 to 10.33; P < 0.01) was also seen on multivariate analysis (Table 4) . After accounting for DFI less than 1 year or more than one IT lesion being present, the cumulative probability of local failure was not found to differ with respect to gross margins greater than or less than or equal to 5 mm (P = 0.358).
| Cumulative incidence of any recurrence-local, regional, or distant
The overall cumulative incidence of any recurrence was 71.3% (95% CI, 60.3 to 79.3) at 2 years after IT resection. Univariate analysis found that the incidence of any failure differed with respect to whether DFI was less than a year (P = 0.03) and if more than one lesion was present (P = 0.014) ( Table 3 ). The 2-year cumulative incidence of any failure for patients with DFI less than or equal to 1 year was 75.2% (95% CI, 58.5% to 85.2%) and 71.3% (95% CI, 54.5% to 81.9%) in those with DFI over a year. The 2-year cumulative incidence of any failure for patients with more than one IT lesion at the time of first IT event was 82.3% (95% CI, 56.7% to 92.7%) and 67.5% (95% CI, 54.3% to 76.9%) in those with a single lesion. No significant associations were found between incidence of any recurrence and age greater than 65 years old at first IT event (P = 0.08), sex (P = 0.31), location of the primary (head and neck vs trunk: P = 0.09), diameter of the largest IT lesion greater than or equal to 10 mm (P = 0.17), or gross margin greater than 5 mm (P = 0.33).
Multivariate analysis found that the higher failure rates were associated with less than a year DFI (HR, 1.70; 95% CI, 1.10 to 2.6; P = 0.02) and more than a single IT lesion (HR, 2.4; 95% CI, 1.5 to 3.7; P < 0.01) ( Table 4) .
| DISCUSSION
Our study supports the premise that the onset of IT disease is associated with a poor prognosis and often precedes the development of systemic metastasis. Moreover, isolated local failure following surgical excision of an IT lesion is uncommon. The 2-year cumulative event rate within 2 cm of a previous IT resection was 19.5%; however, the majority of these were not isolated but were associated with other recurrences (IT, regional, or distant). The 2-year cumulative recurrence rate after resection of a first IT event was 71.3%. The factors associated with a higher incidence of any recurrence were more than one IT lesion at the first IT event and a short DFI between primary diagnosis and the first IT event.
Wider In-transit + regional metastases 3 (2.3)
Regional + distant metastases 6 (4.6)
In-transit + regional + distant metastases 2 (1.5)
Forty-seven patients died during our study time period: 37 died with disease progression, 7 died without evidence of disease, and 3 died with unknown disease status.
a Five patients died without documentation of the disease recurrence. 
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The 5-year survival for patients with IT disease is poor, but there seems to be a subgroup of patients that will be cured with local excision alone. In our series, 43 patients did not recur with a median follow-up of Previous studies have looked at prognostic factors related to survival after IT disease, none to our knowledge, have specifically addressed the influence of gross margins on the natural history of the disease. 
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T A B L E 3 Estimated cumulative incidence of local recurrence and any recurrence after surgical excision of the first in-transit event Local, satellite, and IT metastases are all part of the same disease spectrum that is distinguished arbitrarily by distance from the primary resection scar. We specifically chose to look at the association that margin width could have on the development of disease within 2 cm of the resected IT lesion as this appears to have the most clinical practicality. Ultimately, disease developing so close to the previous IT site is an outcome that a surgeon could potentially prevent by opting wider surgical margins. As a result of our goal we grouped all the events within 2 cm of the IT resection together, thus including some that historically would have been referred to as satellites.
| CONCLUSION
In conclusion, for patients presenting with a first IT event that is resectable, we found both the incidence of local failure and the incidence of any recurrence was increased in patients with more than one IT lesion and a DFI between primary diagnosis and IT event of less than a year. We did not find a significant difference in either the Narrower clinical margins of resection are acceptable and should be made on a case to case basis to decrease morbidity since isolated local failure near the IT excision is rarely a concern.
T A B L E 4 Multivariate analysis of the factors associated with local recurrence or any recurrence 
